Physiomics PLC (PYC)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

0.50p

Buy

0.55p

arrow-up0.00p (+0.00%)

Prices updated at 12 Jun 2026, 16:36 BST

Prices minimum 15 mins delay

Prices in GBX

Physiomics PLC is a United Kingdom-based firm that provides consulting services to biopharmaceutical companies and research institutes in the areas of outsourced modelling and simulation (quantitative pharmacology), biometrics, and data science (bioin ...

FTSE All-Share

1.61%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2024	2025
	543,250	784,005
	-	-
	-670,816	-457,791
	-123.48	-58.39
	-609,352	-415,254
	-659,771	-448,206
Sales, General and administrative	-	-
Interest expenses	33	-
Provision for income taxes	-59,402	-42,015
Operating expenses	1m	1m
Income before taxes	-668,754	-457,269
Net income available to common shareholders	-609,352	-415,254
	-0.0042	-0.0015
Net interest income	2,062	522
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	-0.0042	-0.0015
Free cash flow per share	-0.0042	-0.0023
Book value/share	0.0014	0.0023
Debt equity ratio	-	-

Balance sheet

Year chevron-l-regular chevron-r-regular	2024	2025
Current assets	401,395	875,946
Current liabilities	140,076	199,855
Total capital	282,527	692,171
Total debt	-	-
Total equity	282,527	692,171
Total non current liabilities	-	-
Loans	-	-
Total assets	422,603	892,026
Total liabilities	-	-
Cash and cash equivalents	191,072	461,242
Common stock	135m	303m

Cash flow

Year chevron-l-regular chevron-r-regular	2024	2025
Cash at beginning of period	416,592	191,072
Cash dividends paid	-	-
	-565,443	-550,078
Investments (gains) losses	-15,215	-3,413
	191,072	461,242
Net income	-	-
	-548,133	-546,143
	-17,310	-3,935

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.